Business UpdateJun 22, 2026, 08:46 AM
SeaStar Medical CEO to Present at Virtual Investor Summit
AI Summary
SeaStar Medical Holding Corporation announced that its Chief Executive Officer, Eric Schlorff, will present at the Virtual Investor Summit Conference on June 24th at 10:30 am ET. The presentation will be available live online, with a replay accessible on the company's website for 30 days. SeaStar Medical is a commercial-stage healthcare company with an FDA-approved product, QUELIMMUNE®, and an ongoing pivotal clinical trial for adult Acute Kidney Injury.
Key Highlights
- SeaStar Medical CEO Eric Schlorff will present at the Virtual Investor Summit Conference.
- The presentation is scheduled for Wednesday, June 24th, at 10:30 am Eastern Time.
- Interested investors can register and view the live presentation online.
- A replay of the presentation will be available on the Company's website for up to 30 days.
- SeaStar Medical's QUELIMMUNE® (SCD-PED) was FDA-approved in 2024 for pediatric AKI.
- The company's SCD therapy has Breakthrough Device Designation for six indications.
- The NEUTRALIZE-AKI pivotal clinical trial for adult AKI is currently ongoing.
Price Impact
More from ICU
More in Business Update